Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

Part of the body’s natural defense system against cancer involves dendritic cells taking up tumor ... In the tumor, chronic activation yields stem–like T cells and killer T cells that express ...

These damage-associated molecular patterns can act as natural immune adjuvants by binding to pattern recognition receptors on the surface of dendritic cells, promoting their maturation and ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer.

The new approach described in Cell Reports works by targeting a specific molecular subunit of “NMDA” receptors that they ... a physical shrinking of the dendritic “spine” structures ...

[35] Following skin transplantation, cutaneous dendritic cells ... APC: Antigen-presenting cell; TCR: T-cell receptor.

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...

Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...